Page 4 - நோயியல் தொழிலாளர்கள் பன்முகத்தன்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நோயியல் தொழிலாளர்கள் பன்முகத்தன்மை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நோயியல் தொழிலாளர்கள் பன்முகத்தன்மை Today - Breaking & Trending Today

Report reveals 72,500 rural and remote Australians admitted to hospital each year due to medicine-related problems


Date Time
Share
Report reveals 72,500 rural and remote Australians admitted to hospital each year due to medicine-related problems
Pharmaceutical Society of Australia
A new report has revealed 1.3 million rural and remote Australians do not take their medicines at all or as intended adding an estimated $2.03 billion to our annual health care costs.
The Medicine Safety: Rural and remote care report, developed for the Pharmaceutical Society of Australia by Charles Sturt University, also found that 72,500 rural and remote Australians are admitted to hospital each year due to problems with their medicines, costing the health care system $400 million.
The report will be launched by NSW Health Minister Brad Hazzard in Sydney on Saturday 13 March. ....

New South Wales , Chris Freeman , Brad Hazzard , Society Of Australia , Charles Sturt University , Aboriginal Community Controlled Health Organisations , Medicine Safety , Pharmaceutical Society , Minister Brad Hazzard , President Associate Professor Chris Freeman , Prof Freeman , Indigenous Australians , Nsw Health , Chronic Disease , Health Minister , Mental Health , புதியது தெற்கு வேல்ஸ் , கிறிஸ் ஃப்ரீமேன் , பிராட் தீங்கு , சமூகம் ஆஃப் ஆஸ்திரேலியா , சார்லஸ் ஸ்டர்ட் பல்கலைக்கழகம் , தொன்முதுவர் சமூக கட்டுப்படுத்தப்படுகிறது ஆரோக்கியம் ஆர்கநைஸேஶந்ஸ் , மருந்து பாதுகாப்பு , மருந்து சமூகம் , அமைச்சர் பிராட் தீங்கு , ப்ரெஸிடெஂட் இணை ப்ரொஃபெஸர் கிறிஸ் ஃப்ரீமேன் ,

Whole genome sequencing may guide blood cancer treatment


Whole genome sequencing may guide blood cancer treatment
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes.
Some of these tests rely on technology that was invented more than 60 years ago and has been used clinically for the past three decades.
Now, a new study from Washington University School of Medicine in St. Louis shows that whole genome sequencing is at least as accurate and often better than conventional genetic tests that help determine the treatment for a patient s blood cancer. Genome sequencing technology continuously is decreasing in cost and recently reached a level similar to that of conventional testing. In addition, results can be returned to patients in just a few days, making whole genome sequencing a potentially viable approach for determining the best treatment regimen for a parti ....

Ericj Duncavage , Mollyc Schroeder , Peter Campbell , Davidh Spencer , Emily Henderson , Mcdonnell Genome Institute , Washington University , Siteman Cancer Center At Barnes , Wellcome Sanger Institute In Cambridge , Washington University School Of Medicine , Siteman Cancer Center , Department Of Pathology Immunology , Washington University School , New England Journal , Study Senior Author , Assistant Professor , Medical Director , Clinical Sequencing Facility , Mcdonnell Genome , Barnes Jewish Hospital , Siteman Cancer , Wellcome Sanger Institute , Blood Cancer , Whole Genome Sequencing , Acute Myeloid Leukemia , Bone Marrow ,

Early Release - Intersecting Paths of Emerging and Reemerging Infectious Diseases - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal


 
Author affiliations: Universidade de Brasília, Brasília, Brazil (T.M. Wilson); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (T.M. Wilson, C.D. Paddock, S. Reagan-Steiner, J. Bhatnagar, R.B. Martines, H. Venkat, S.R. Zaki); Pinal County Office of the Medical Examiner, Florence, Arizona, USA (A.L. Wiens); Coconino County Health and Human Services Medical Examiner’s Office, Flagstaff, Arizona, USA (M. Madsen); Arizona Department of Health Services, Phoenix, Arizona, USA (K.K. Komatsu, H. Venkat)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shares common clinicopathologic features with other severe pulmonary illnesses. Hantavirus pulmonary syndrome was diagnosed in 2 patients in Arizona, USA, suspected of dying from infection with SARS-CoV-2. Differential diagnoses and possible co-infections should be considered for cases of respiratory distress during the SARS-CoV-2 pandemic. ....

United States , Centers For Disease , National Center , Infectious Diseases Pathology Branch , Division Of High , Sin Nombre , Four Corners , High Consequence Pathogens , Zoonotic Infectious Diseases , Disease Control , During May , Capes Print Program , Coronavirus Disease , Covid 19 , Severe Acute Respiratory Syndrome Coronavirus 2 , Sars Cov 2 , Peromyscus Maniculatus , Sin Nombre Virus , Hantavirus Pulmonary Syndrome , Vector Borne Infections , Respiratory Infections , Immunohistochemical Analysis , Co Infection , Differential Diagnoses , ஒன்றுபட்டது மாநிலங்களில் , மையங்கள் க்கு நோய் ,